Rebecca Weil
Corporate Officer/Principal en OCULIS HOLDING AG .
Cargos activos de Rebecca Weil
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OCULIS HOLDING AG | Corporate Officer/Principal | 11/09/2023 | - |
Historial de carrera de Rebecca Weil
Antiguos cargos conocidos de Rebecca Weil.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| IDORSIA LTD | Ventas & Marketing | 01/07/2019 | 01/08/2023 |
| SHIRE | Corporate Officer/Principal | 01/08/2016 | 01/03/2019 |
| Juvenile Diabetes Research Foundation (New York) | Director/Miembro de la Junta | - | - |
| BAUSCH + LOMB CORPORATION | Ventas & Marketing | - | - |
| NOVARTIS AG | Corporate Officer/Principal | - | - |
| ALCON INC. | Corporate Officer/Principal | - | - |
Formación de Rebecca Weil.
| Massachusetts Institute of Technology | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Estadísticas
Internacional
| Suiza | 5 |
| Estados Unidos | 4 |
| Irlanda | 2 |
Operativa
| Corporate Officer/Principal | 4 |
| Sales & Marketing | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 7 |
| Finance | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| OCULIS HOLDING AG | Health Technology |
| IDORSIA LTD | Health Technology |
| ALCON INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| BAUSCH + LOMB CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Juvenile Diabetes Research Foundation (New York) |
- Bolsa de valores
- Insiders
- Rebecca Weil
- Experiencia
